“…In this model, the substantial overall RTD of anticodon stem SUP4oc variants is due to a combination of pre-tRNA RTD, triggered by their altered intron-exon structure and presumed inefficient splicing, coupled with the distinct, but relatively inefficient, 5'-3' decay of anticodon stem variants after splicing, resulting in similar overall RTD to that of acceptor stem variants. Subsequent to maturation, tRNAs with destabilizing mutations or lacking specific body modifications are targeted by the RTD pathway (19,20,49,54), particularly at elevated temperatures, which leads to increased instability and attack (48,55). RTD is in competition with cellular proteins that bind charged tRNA, including EF-1A (49, 88) and tRNA synthetases such as ValRS for RTD of tV(AAC) (88).…”